{
  "name": "Ulipristal acetate 5mg prescribing for uterine fibroids",
  "title": [
    "Ulipristal acetate 5mg prescribing for uterine fibroids"
  ],
  "description": [
    "Number of items for ulipristal acetate 5mg per 1000 patients"
  ],
  "numerator_short": "Items",
  "denominator_short": "1000 Patients",
  "openc_numerator_name": "Ulipristal acetate 5mg",
  "why_it_matters": [
    "The <a href='https://www.gov.uk/drug-safety-update/esmya-ulipristal-acetate-suspension-of-the-licence-due-to-risk-of-serious-liver-injury'> MHRA has a clear safety direction advising that</a>",
    "patients taking Esmya (ulipristal acetate) for uterine fibroids should <b>STOP</b> their treatment <b>IMMEDIATELY</b>.",
    "<p>Any prescribing on this measure should prompt investigation to identify patients and ensure the treatment is stopped and followup blood tests arranged.</p>",
    "<p>Please note that this is an experimental measure to support a new type of alert. We would be grateful for",
    "any feedback at <a href='mailto:feedback@openprescribing.net?Subject=ulipristal%20measure'>feedback@openprescribing.net</a>.</p>"
  ],
  "tags": [
    "safety",
    "reproductive"
  ],
  "url": null,
  "is_percentage": false,
  "is_cost_based": false,
  "low_is_good": true,
  "numerator_type": "bnf_items",
  "numerator_bnf_codes_filter": [
    "0604012U0 # ulipristal"
  ],
  "denominator_type": "list_size",
  "authored_by": [
    "brian.mackenna@phc.ox.ac.uk"
  ],
  "checked_by": [
    "richard.croker@phc.ox.ac.uk"
  ],
  "date_reviewed": [
    "2020-04-02"
  ],
  "next_review": [
    "2020-10-02"
  ],
  "measure_notebook_url": [
    ""
  ],
  "measure_complexity": [
    "low"
  ]
}
